Zepp Health Corporation (NYSE: ZEPP) has announced its financial results for the fourth quarter and the full year of 2023 in a recent earnings call, emphasizing a strategic shift towards self-branded products and a focus on research and development (R&D), profitability, and branding.
The company reported a record gross margin of 34.7% for Q4 2023 and strong sales of $85 million. Despite the positive performance, Zepp Health remains cautious about its Q1 2024 revenue projections, aiming to maintain market share without compromising on margins.
Key Takeaways
- Zepp Health's Q4 2023 sales reached $85 million with a record gross margin of 34.7%.
- The strategic shift to self-branded products results in them contributing to 91% of the company's top line.
- The company launched new products, including the Amazfit Helio Ring and Zepp OS 3.5 with Zepp Flow.
- Zepp Health maintains a strong cash balance of approximately $140 million and reported an adjusted operating profit of $2.4 million in Q4 2023.
- Q1 revenue is projected to be between $42 million and $49 million, with self-branded products driving around 90% of the revenue.
- The company's regional strategy prioritizes the EMEA region, the USA, and the Asia Pacific, with plans to capitalize on major sports events and expand into offline channels in the USA.
- Zepp Health holds a minority share in a China A-Stock listed company, aligning with their vertical integration strategy for wearables.
- The company aims for a no or close to no debt situation by the end of 2024, having paid down over RMB200 million in debt in 2023.
Company Outlook
- Zepp Health is investing in R&D and marketing initiatives to drive innovation and expand distribution channels.
- The company plans to leverage big sports events like the Olympics and European cup to boost sales in Europe.
- Expansion into offline channels in the USA is underway, with partnerships in place with major retailers such as Best Buy (NYSE:BBY), Target, and Walmart (NYSE:WMT).
- Growth opportunities are identified in the Asia Pacific region, particularly in Thailand, Japan, and Taiwan.
Bearish Highlights
- Some Q4 2023 sales may have been advanced from Q1 2024 due to successful promotions, prompting a cautious Q1 revenue outlook.
- The consumer electronics industry faces ongoing challenges that Zepp Health must navigate to sustain growth.
Bullish Highlights
- The company's profitability focus is starting to pay off with the highest recorded gross margin in its history.
- Zepp Health benefits from its investment in a China A-Stock listed company, aiding in the vertical integration of its wearables plan.
Misses
- There were no specific misses reported during the earnings call.
Q&A Highlights
- Zepp Health clarified that their long-term debt is primarily associated with the purchase of the minority stake in the Chinese listed company, which does not affect their strong cash balance.
- The company has no plans to sell its stake in the China A-Stock listed company and is focused on reducing its debt to achieve a nearly debt-free status by the end of 2024.
In conclusion, Zepp Health Corporation is actively refining its strategy to enhance its market presence through self-branded products and a robust regional approach. The company's financial health appears stable, with a clear plan for growth and debt management in the coming years.
InvestingPro Insights
Zepp Health Corporation's strategic focus on self-branded products and a robust gross margin in Q4 2023 reflect a company that is streamlining its operations for efficiency. However, the InvestingPro data suggests that investors should be aware of the challenges the company faces.
With a market capitalization of $74.47 million and a price to book ratio of 0.21 as of the last twelve months ending Q3 2023, Zepp Health is trading at a low valuation multiple, which could indicate that the market has not fully recognized the company's asset value.
InvestingPro Tips indicate that Zepp Health is a prominent player in the Electronic Equipment, Instruments & Components industry, but analysts are expecting a sales decline in the current year, and the company is not projected to be profitable this year.
These insights are particularly relevant given the company's cautious revenue outlook for Q1 2024. Moreover, the stock has been characterized by high price volatility, which may be a concern for investors looking for stable returns.
Despite the reported sales decline and profitability concerns, Zepp Health's self-branded products, which contributed to 91% of the company's top line, could be a key factor in its long-term strategy. The company's regional strategy and expansion into offline channels in the USA, mentioned in the article, could potentially counterbalance the negative sales projections.
For investors interested in a deeper analysis, there are 10 additional InvestingPro Tips available for Zepp Health, which can provide more nuanced insights into the company's financial health and market position. Readers can use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription at InvestingPro for more detailed insights and tips on Zepp Health and other companies.
Full transcript - Zepp Health Corp (ZEPP) Q4 2023:
Operator: Hello, ladies and gentlemen. Thank you for standing by for Zepp Health Corporation's Fourth Quarter and Full Year 2023 Earnings Conference Call. At this time, all participants are in listen-only-mode. Today's conference call is being recorded. I will now turn the call over to your host, Ms. Grace Zhang, Director of Investor Relations for the company. Please go ahead, Grace.
Grace Zhang: Hello everyone, and welcome to Zepp Health Corporation's fourth quarter and full year 2023 earnings conference call. The company's financial and operating results were issued in a press release via the newswire services earlier today and are posted online. You can also view the earnings press release and slides referred to on this call by visiting the IR section of the company's website at zepp.com. Participating in today's call are Mr. Wang Huang, our Chairman of the Board of Directors and Chief Executive Officer and Mr. Leon Cheng Deng, our Chief Financial Officer. The company's management will begin with prepared remarks, and the call will conclude with a Q&A session. Mr. Mike Yeung, our Chief Operating Officer, will join us for the Q&A session. Before we continue, please note that today's discussion will contain forward-looking statements made under the safe harbor provisions of the US Private Securities Litigation Reform Act of 1995. Forward-looking statements involve inherent risks and uncertainties. As such, the company's actual results may be materially different from the views expressed today. Further information regarding this and other risks and uncertainties are included in the company's annual report on Form 20-F for the fiscal year ended December 31, 2022, and other filings as filed with the US Securities and Exchange Commission. The company does not assume any obligation to update any forward-looking statements, except as required under applicable law. Please do note that GAAP earnings press release and this conference call include discussions of unaudited GAAP financial information as well as unaudited non-GAAP financial information. Zepp's press release contains a reconsolidation of the unaudited non-GAAP measures to the unaudited most directly comparable GAAP measures. I will now turn the call over to our CEO, Mr. Wang. Please go ahead.
Wang Huang: Hello, everyone. Welcome and thank you for joining our call. In 2023, amidst global microeconomy uncertainties, our ROI [ph] oriented strategy and ongoing business model transformation began to bear fruit. This strategy shift has enabled us to strengthen our commitment to becoming a global provider of cutting edge, smart, wearable healthcare solution. Before we dive into our earnings, I would like to spend some time talking about our strategy as we reflect on 2023. Over the past 2 years, we have been on a transformative journey to become less dependent on Xiaomi (OTC:XIACF) branded products and instead develop a self reliant company driven by its self branded product sales. This shift is starting to show promising results, as evidenced by our two consecutive non-GAAP profitable quarters. Looking at 2024, building on the actions we have taken in the past, we are excited to be making a strategic leap and harnessing the synergy between our product and sales channels. This leap forward is grounded in three core pillars. First, we are putting greater emphasis on R&D and product driven innovations where we will fully embrace AI and offer more innovative products that closely align with needs of our key markets. Second, we are continuing to ensure profitable growth, maximizing the value we derive from each and every product showed. Guided by this approach, we are choosing profitability over scale in some regions, such as India, which transitioned in 2023 from a loss making market to a profitable one. In certain other areas, we are investing aggressively to gain market share, aiming to generate long-term returns. Last but not least, we will invest in branding and marketing communications in order to enhance our brand presence by welcoming our Amazfit athletes and increasing sponsorships of big sports events. I believe you will see the Amazfit brand more visible across the world in the coming quarters. With these three pillars, I am confident we can propel our frank view and generate a higher return from our employees and shareholders in the long run. In the fourth quarter of 2023, our focus on strategic transformation towards a more self reliant revenue stream has gained traction, aimed at reducing dependency on a single customer, lowering revenue concentration and shifting our emphasis increasingly on self branded products. These efforts to become self relent have made significant progress. As a result, despite a year-over-year decline in our revenue during the fourth quarter, our self branded products maintained a sequential growth momentum with a quarter-over-quarter growth of 14.8% and contributed to 91% of our top line, up from 77% in the previous year. Notably, our gross margin reached a record high in the fourth quarter, a testament to our effective prioritization of profitability over scale. This significant achievement was largely driven by our higher margin self branded products. The launch of the Amazfit Active and Amazfit Active Edge series in Q4, as well as the Amazfit Balance special edition, enhanced our product portfolio and significantly elevated our market presence. At the same time, we will continue to prove our retail channels and enhance our product mix to sustain the higher gross margin trend, leveraging self branded revenue to bolster the company's overall performance and steering us towards sustained profitability. To further solidify our market leading position in smart variables, we continue diversifying our product lineup to meet evolving market demand. In October, we launched two new lifestyle smart watches, the Amazfit Active and the Amazfit Active Edge in Europe and APAC. These smart watches tailored for today's urban - urbanized branding elegance with powerful functionality, incorporates the AI powered Zepp Coach and effortlessly integrate into our users hectic lives. At Zepp, innovation is at the core of everything we do. To reflect this vision, I would like to highlight some of our success in smart wearable technology at CES 2024. The CES launch of the Amazfit Helio Ring, our first smart ring, underlines our dedication to providing pioneering accessible healthcare solutions. The Amazfit Helio Ring is designed to offer unparalleled recovery support to athletes. These developments in patronize our commitment to empowering individuals to take control of their health and well being through our smart variables. Building on the momentum of our product expansion, we remain dedicated to leveraging Zepp OS. We recently introduced Zepp OS 3.5 with Zepp Flow at MWC Barcelona 2024 in February, a substantial update powered by large language model AI, marking a significant leap in wearable intelligence devices and bringing unprecedented levels of interaction. Zepp Flow offers seamless natural language liquidation to provide users with exactly what they want, from setting an alarm, deactivating the always on display feature to providing feedback on last night's sleep quality and analyzing the readiness score from the previous day's activities and offering recommendations for improvement in the following days. All can be done by interactivating with the watch, using human natural language and without the need to memorize any predefined commands. Additionally, we provide our users with consistent software updates. For example, the Amazfit Balance now features new training templates, new ski map functions and enables smart NFC car payment in Europe, enhancing both the sporting experience and general daily convenience. Our blood pressure measurement software has been extended to a broader range of products including the Amazfit Falcon, Active Cheetah Pro, Amazfit T-Rex Ultra, Amazfit T-Rex 2 and GTR 4, aiming to deliver personalized and advanced wellness support to a greater number of users. Our products seamless integration of hardware and software not only assists users to improving their well being, but also elevates their lifestyle style. I'm happy to share a comparing example that comes from one of our Japanese users who found himself low [ph] in a snowstorm during a hiking trip in Mont Blanc. Fortunately, our T-Rex 2 guided him safely back. He shared his experience on Yamap, Japan's leading outdoor app, and even sent us a thank you email. Stories like these fill us with pride as we see our products contribute to the enthusiasm and satisfaction of our users. 2023 leaves behind a tapestry woven with both challenges and triumphs. As we are transforming into a self reliant company and shifting our strategy from pursuing pure revenue growth to profitability, we have seen a decline in revenue despite that our Amazfit branded products contributed to 74% of our total revenue compared to 59% in 2022. Furthermore, our efforts translated into a commendable 36% reduction in non-GAAP net loss, marking a pivotal shift for us as we achieved profitability in both Q3 and Q4, leveraging our gross margin and cost management strategies. Another operational milestone in Q4 2023 was the successfully completed mass production of our Amazfit Bip watch line at our Vietnam factory. This achievement not only underscores the execution of our multi-sourcing global supply chain strategy, but also paves the way for further global expansion. Additionally, we have witnessed a surge in product visibility, particularly on social media platforms and through key opinion leader's endorsements, including a growing market presence and heightened consumer engagement. Looking to the future, we see a healthy and sustainable growth trajectory for Zepp. Our relentless drive for innovation and strategic expansion of our product offerings positions us to effectively adjust the evolving demands of our global user community. Despite headwinds posed by macroeconomic challenges, our focus remains steadfast on bolstering profitability and seeking dynamic opportunities to propel our resilient growth and secure greater bottom line stability. This approach not only strengthens our competitive edge, but also ensures our long-term success in the ever-evolving smart wearable industry. I will now turn the call over to Leon to go over the highlights of our fourth quarter financial results.
Leon Cheng Deng: Thank you, Wang. Greetings, everyone. And thank you again for joining our earnings call today. I would like to start by discussing some key metrics from our financial results for the fourth quarter of 2023. As we have mentioned in the past, the border consumer electronics industry has yet to recover and remains subdued across our geographies. This is partially due to a sluggish demand for high value consumer electronics products such as TV and mobile phones, coupled with challenging economic conditions in parts of the EMEA and APAC regions. However, we saw some modestly improved performance in the smartwatches for outdoor/ sports category, though the market remains highly competitive. Aimed at these challenges, we steadfastly adhered to our strategic plan. This holiday season, we took an unconventional approach by launching that extended pre-Christmas promotion in selected products. Traditionally, we focused on offering discounts centered around Black Friday and Cyber Monday. However, this year we decided to align with consumer expectations for ongoing discounts throughout the holiday season. This strategy resonated well with our consumers. We have met our own sales expectations while delivering strong gross margins for the quarter. All of this is a testament to our strong brand, our great product lineup and the value that our products can offer. However, given that the successful promotion occurred later in the fourth quarter, it is likely that it might have advanced some sales from Q1 of 2024. Since Q1 is typically our slowest quarter of the year, we're adopting a more cautious outlook for the revenue projections in the upcoming quarter. I would like to emphasize that we are laser-focused on the areas within our control. We're holding our market share steady without sacrificing gross margin. As we stand at the start of a multiyear product cycle, we're beginning to harvest the benefits of our research and development investments. This allows us to branch into new categories and introduce innovative products such as the Helio Ring we unveiled at CES, with more announcements planned for the coming quarters. We are also broadening our distribution channels to align with where our customers prefer to shop. Additionally, we're reinventing our brand marketing and activation to tap into sports and address new audiences. As Wang [ph] highlighted earlier, you will see our brand featured more prominently at sports events and will welcome more athletes to join our Amazfit family. Such strategic positioning of the company aims to accelerate our growth while managing expenses carefully to ensure margin expansions in the years to come. Now, turning to Q4 sales, our overall sales for the quarter was US$85 million/0.6 billion, aligned with the lower end of our guidance as we navigated the technical challenges in our categories and a highly promotional environment. This reduction in sales was influenced partially by our strategic decision to prioritize profitability over scale, with foreign exchange fluctuations also having a negative impact. In markets like China and India, our business model mirrors this emphasis on profitability over scale. The shift has resulted in these markets turning net profit positive in 2023. Furthermore, despite year-over-year revenue declines in our self branded products, we achieved positive quarter-over- quarter revenue growth, convincing us that our strategic approach will empower our business long-term sustainability and resilience. Moving on to gross margin, which can be influenced by various factors such as product mix, product launch timing and product lifecycles, including model upgrades. As Wang indicated earlier, our Q4 2023 gross margin reached an impressive 34.7%, surpassing Q3 and marking the highest gross margin in the company's history. This achievement can be attributed to a favorable product mix, a higher proportion of new product launches such as Amazfit Active and Amazfit Active Edge series and reduced clearance activities. Importantly, we anticipate this positive trend in gross margin to extend into Q1 and throughout 2024. Now, let's turn our attention to costs. As we have discussed, cost management remains as a critical area of focus for our company, both in terms of their absolute amount and as a percentage of sales. Hence, we continue to exercise disciplined control over our expenses during the quarter. Since Q3 2020, we have consistently reduced over operating costs, all while strategically investing in innovative products and technologies, as well as geographical expansion. As a result, non-GAAP operating expenses for Q4 stood at US$27 million RMB191 million, comparable with Q3 2023 and consistent with the guidance which we provided. Adjusted research and development expenses in the fourth quarter of 2023 was $11 million, a decrease of 30.8% year-over-year. This comprised 12.8% of revenue versus 10% for the same period in 2022. The decrease was primarily attributed to our refined research and development strategies, as we constantly access resources efficiently to maximize return on investment and productivity. Also, we integrated an AI-based R&D platform to improve our efficiency. At the same time, we're committed to investing in new technologies and AI functions to maintain our competitive edges against our peers. Adjusted selling and marketing expenses in the fourth quarter of 2023 was US$12 million, a year over year decrease of 31%. These expenses accounted for 14.3% of revenues compared to 11.6% in the same period in 2022. The reduction in amount was mainly due to our ongoing efforts to improve profitability and refine our sales channel mix. In addition to the in depth enhancement of our retail channels, such efforts also included a strategic allocation of staff throughout our sales region. Additionally, we launched Amazfit Wellness Wonderland at a pop up store in Berlin to spotlight wellness during the holiday season. We showcased our brand concept through a collaboration with Siciliano Contemporary play at the launch of the Amazfit Balance special edition watch, drawing significant media attention. This concept was also highlighted in the Zepp Health's 10 years of innovation campaign. We are committed to making smart investments in marketing and branding initiatives that will fuel our longer growth. Adjusted G&A expenses amounted to US$4.0 million in the fourth quarter of 2023, a year-over-year decline of 37.8%. These expenses represented 4.8% of revenues compared with 4.3% in 2022. This decrease in absolute amount was largely attributed to our efforts in optimizing personnel and enforcing strict cost control over administrative expenses. Looking ahead, our commitment to prudent cost management will continue in the coming quarters, with anticipated costs remaining at or below our current levels. We'll maintain our strategic investments in R&D activities and market expenses to ensure our long-term competitiveness, striking a balance between strictly monitoring discretionary spending and making strategic investment critical for our long-term growth. In Q4 2023, we reported an adjusted operating profit of US$2.4 million, RMB17 million, which includes a non-cash US%3.5 million valuation allowance of deferred tax assets versus the operating loss of US$8 million in the same period last year as a result of the expansion in our self branded products gross margin and our streamlined operating expenses. Now, turning to the balance sheet, as of December 31, 2023, our cash and cash equivalents along with restricted cash balance totaled approximately US$140 million/ RMB1 billion. This positions us with ample runway to capitalize on potential marketing opportunities and invest in our business growth. We have also focused on managing our working capital efficiently. We kept inventory levels steady at US$ 85 million, RMB600 million, the lowest level in the company's history. We'll continue to manage inventory levels tightly as we weather the macroeconomy. In Q4 coupled with operating profits and efficient working capital management, we achieved positive operating cash flow. This marks our sixth consecutive quarters of positive operating cash flow and we expect to continue this position in the coming quarters. Since Q2 2023, we have initiated the retirement of portions of our short and long term debt portfolio, successfully retiring US$4.8 million, RMB34 million of debt in Q2 and USD16 million, RMB170 million in Q.3 In Q4, we continue to reduce our debt levels by another US$12 million, RMB 84 million. As our operating cash continued to strengthen, we intended to do more in the coming quarters. Furthermore, by the end of December 31, 2023, we had repurchased shares worth $12.9 million. We remain committed to continue our buyback program in the fourth quarter and in the quarters following that, underscoring our confidence in the company's future and our commitment to delivering long-term value to our shareholders. Looking ahead as I mentioned before, Q1 is traditionally a soft quarter for us. Therefore, our Q1 guidance range is projected to be US$42 million to US$49 million, RMB300 to RMB350 million, with self branded products accounting for about 90% of the revenue. In conclusion, the fourth quarter presented challenges that we overcame by prioritizing profitability over scale. This strategy, combines our disciplined approach to cost management, has been instrumental in achieving encouraging performance and delivering a second consecutive quarter of non-GAAP profitability for us. As we look ahead, we remain confident that these strategic initiatives will continue to deliver long-term value to our investors and shareholders, as well as our employees. Thank you all for your time. I would now like to open the call for any questions. Operator, please go ahead.
Operator: Thank you. We will now begin the question-and-answer session. [Operator Instructions] Our first question today will come from Nicolette Jones [ph] of Brooks Investments. Please go ahead.
Unidentified Analyst: Hi. I have two questions. Please could management provide more details on the outlook for 2024 and the first quarter? And for my second question, I'd like to find out more about the company's regional strategy?
Wang Huang: Nicolette, I mean, if you could repeat the second question one more time for me, please.
Unidentified Analyst: Oh, yes. Hi. I'd like to - more details on the regional strategy.
Wang Huang: Okay. On the regional strategy. Thank you. So let me take this question, I think on your first question, on the outlook for first quarter, and also on 2024, I think on the first quarter, I just mentioned that typically it is a relatively soft quarter for the consumer electronics industry. Therefore, our guidance for the first quarter was between the range of $42 million to $49 million, or RMB equivalent to RMB300 to RMB350 million for the top line. And normally our guidance stops at giving the guidance only for the revenue. But in this call, I think I want to provide some color on full year 2024, as you asked. I think looking at the full year 2024, if we start from the big picture, both IDC and Catalyst actually are projecting overall market value growth for the smartwatch sector, which is the sector which we're operating in, of single digit, high single digit growth for year 2024. Therefore, I think our revenue growth target for 2024 at this juncture, to the best of our knowledge, is actually going to be on par with or higher than the overall market growth for our self branded products on the top line, right. So I think that's the guidance on the 2024 for the full year, for the sales. And coming to gross margin. As you heard what we just mentioned, that our overall gross margin percentage as a percentage of sales actually hovered in the second half of 2023 of somewhere between 30% to 35%. And we expect this gross margin to expand in the upcoming quarters and throughout 2024. Therefore, I think it's reasonable that you could anticipate that our gross margin performance is going to be at least on par with second half of 2023, or even higher than that, right. And then the last missing puzzle of this is actually the operating cost, which is, I think we have mentioned that the run rate of our quarterly operating cost is around RMB200 million-ish. And we have actually maintained this run rate for more than four quarters throughout 2023. And we have been demonstrating that we're able to keep on with this cost level and adjusted this level if we need in the year to come. So I think that should give you a feeling on where the year 2024 would bring us on the bottom line in this case. I think that should give you assess [ph] on the first quarter guidance and the full year 2024. Then I'm actually coming to your second question, which is our regional strategy. I think for a lot of analysts, including yourself following us, you must know that majority of our sales revenue is actually coming from the overseas market, with more than half of the revenue coming from the EMEA region. And then for the remainder, we have half of that coming out of USA and the other half coming out of Asia Pacific region, right. So - and I think looking at 2024, there are a few big events in front of us being the Olympics in Paris in Europe, and also the European cup, which is a soccer game also in July - and June July time frame in Europe. So Europe will be a big sports year for us. And for sure, we will also bank on those big sports events in order to boost our sales for the company. And not to mention that USA actually stands as another bright spot for growth for us because we have made quite some advancement in the offline channels in US. For example, we are featured in Best Buy, Target and many offline channels, and also including Walmart in US at this moment. And we're actually expanding into more stores and also more offline channels in the USA as we speak, which we believe in 2024, we should see a reasonable growth coming out of USA for us as well. I think that is, in a nutshell, where we play in the regional structure, and not to mention that in Asia Pacific region, we have markets whereby we also see a great potential, for example, Thailand, Japan, Taiwan, et cetera, et cetera, where we think we can also make a big leap on our revenue in the year to come.
Unidentified Analyst: Thank you.
Operator: Our next question today will come from Sid Rajeev of Fundamental Resource Corp. Please go ahead.
Sid Rajeev: Hi. Congratulations on your strong results. I have a couple of questions. On your balance sheet, you have close to $250 million in investments. Market cap is just $75 million. So it seems like the market is not recognizing the value of investments you have on your books. What's your plan with these investments on a long term basis? Any plans to divest at least a portion of it in the near term?
Leon Cheng Deng: Yes, I think you are referring to the China A-Stock listed company, which we invested and we took a minority share in that company. I think that company, if you look at it, it is actually placed into the vertical integration of our big plan for the wearables, because that company, to be specific, actually is making the sensors and producing the chips for not only us, but also other wearable manufacturers for the smartwatch product. And then in the future, I think having this company as A-listed company in China has its benefit because it can not only supply goods to us, but also it can supply goods to many other ecosystem companies which want to play in the wearable domain. And I think this is a little bit similar to the Apple (NASDAQ:AAPL) chip strategy, but the only difference is that Apple doesn't open it to the others. And we as a player and a strong player in the smartwatch domain, we would like to actually open up more to the ecosystem within China on the wearables domain, right. And I think also having this listed company in China would benefit this company and our company on the specific semiconductor push which we're going to get from the Chinese market. And it's a highly competitive market. And to some extent, I think if you look at the market value of the A-listed company, multiply our shareholding, the value is already bigger than our market cap per se, right? Which is unfortunately there's something in the equation which does not play or the value has to be fully unleashed in order to realize the full value of this company.
Sid Rajeev: Got it. Thanks.
Leon Cheng Deng: But we have no intent to sell that stake at this moment of time.
Sid Rajeev: Okay. Your cash position is very strong. Someone would expect you to be paying down your debt sooner than what you've been doing. How much of debt would you pay down this year?
Leon Cheng Deng: I think overall in 2023, as I mentioned, actually we paid down more than two, if I remember clearly, I think more than RMB200 million in debt. And at this moment in time, if you look at our balance sheet, we have hardly any short term debt and we only have some long term debt. But majority of that long term debt is actually for the purchase of the stake in the China listed company. And then we have also pledged the shares in order to make that purchase. So in essence, that doesn't play into the health of the overall cash balance I have on Zepp Health, right. And if you look at 2024, we also have similar intent as the probability I just mentioned., and I give a picture on how 2024 would be looking like. I think together with the positive operating cash inflow, we're thinking about retiring similar amount or more than what we did in 2023, in 2024 on the debt portfolio. And that will make us, if we do that by the end of 2024, that will give us no debt or close to no debt situation by year end.
Sid Rajeev: Okay, perfect. Thank you so much, Leon. Thank you, Sid.
Leon Cheng Deng: Thank you, Sid.
Operator: Thank you. As there are no further questions now, I'd like to turn the call back over to the company's IR Director, Grace Zhang, for closing remarks.
Grace Zhang: Thank you once again for joining us today. If you have further questions, please feel free to contact Zepp Health investor relations department through the contact information provided on our IR website. This concludes this conference call. You may now disconnect your line. Thank you.
Operator: The conference has now concluded. Thank you for attending. And you may once again now disconnect.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.